Global Vaccination Against Covid-19: A Collective Responsibility
Written on
Chapter 1: The Urgent Need for Global Vaccination
It is imperative that we vaccinate the entire globe against Covid-19 without delay. The emergence of aggressive new variants means that no one is truly safe until everyone is protected.
> As demonstrated in an interactive map by the New York Times, vaccination rates are alarmingly low in many parts of the world. Regions with darker shades indicate higher vaccination levels, while lighter areas show a lack of coverage.
Recent reports from South Africa have raised concerns, as scientists have identified a new variant of Covid-19 with significantly more mutations than the Delta variant. Countries are now suspending flights from South Africa, with the variant also detected in Botswana, Belgium, Hong Kong, and Israel. As highlighted by the New York Times...
The new variant, known as B.1.1.529, possesses an "exceptionally unusual constellation of mutations," with over 30 mutations in the spike protein alone, according to Tulio de Oliveira, who leads the KwaZulu-Natal Research and Innovation Sequencing Platform. Richard Lessells, an infectious disease expert at the same institution, notes that this variant shows characteristics similar to the Lambda and Beta variants, which are known for their ability to evade immunity.
> "These factors raise concerns that this variant may not only transmit more effectively but might also evade parts of the immune system," Dr. Lessells explained.
While the full implications of these mutations are still unknown, we can only hope they don’t lead to increased transmissibility or severe outcomes. "Substantively, NOTHING is known about the new variant," noted Roberto Burioni, a prominent Italian virologist, urging people not to panic. However, the emergence of new variants underscores a critical point:
It is insufficient for affluent nations to have vaccines; the entire world needs access to them. We are all interconnected in this crisis.
Section 1.1: The Global Vaccination Disparity
Currently, global vaccination rates remain dangerously low, especially in Africa. An interactive map highlights the stark differences in vaccination coverage worldwide. According to a Bloomberg report...
More than half of the 200 countries analyzed by Bloomberg have vaccination rates below 50% of their populations. Over 60 countries, including South Africa — where the latest variant was first identified — have not even reached a 25% vaccination rate.
Given the current production pace of vaccines, global vaccination may not be achieved until well into 2023, with some estimates suggesting it could extend to 2024 or beyond. This presents a significant challenge, not just for those unvaccinated across the globe, but also for individuals in vaccinated countries.
Why is this the case? The rise of new, harmful strains is fundamentally a numbers game. The more individuals Covid-19 infects, the greater the likelihood of mutations occurring, which could lead to the emergence of highly virulent new strains.
> Each infected person can produce anywhere from 1 billion to 100 billion copies of the virus's RNA, creating opportunities for new variants. The replication process is not perfect; it often results in random mutations.
Kelsey Piper of Vox eloquently describes this process...
Most mutations introduced through copying errors tend to have no impact or may even reduce the virus's infectivity. To illustrate, consider a book where most random letter changes would diminish its quality; a beneficial change would be exceedingly rare.
Initially, early variants sparked panic, but many were relatively harmless, showing little difference from the original SARS-CoV-2. However, there remains a risk that random mutations could yield a variant that is more transmissible, virulent, or capable of evading vaccine-induced immunity.
> "By maintaining high case numbers, we increase the likelihood of hitting the jackpot with a new variant," molecular epidemiologist Emma Hodcroft emphasized.
As Piper points out, and public health experts consistently argue, it is crucial to vaccinate as much of the global population as swiftly as possible. Until the entire world has some level of immunity, the coronavirus will continue to have ample opportunity to mutate, potentially leading to devastating new strains that could result in significant loss of life and economic disruption.
Section 1.2: The Challenges of Global Vaccination
The logistics of mass vaccination are complex. As highlighted by a Nature article, each vaccine dose requires numerous industrial production steps, many of which are relatively new, such as large-scale mRNA production, and involve multiple patent holders. However, governments could expedite the process by encouraging and incentivizing short-term technology transfer, enabling pharmaceutical companies to collaborate with other firms globally to share intellectual property and expertise.
Realistically, achieving worldwide vaccination may not be feasible, as Ed Yong noted in his insightful August analysis on "How The Pandemic Now Ends." Some segments of the population may gain immunity not through vaccination but via natural infection, surviving the illness. Yong concluded that our long-term outlook for Covid-19 is “endemicity,” where the virus continues to circulate year after year, but it is no longer novel, as most individuals have either been vaccinated or infected. However, experts remain uncertain about when this will occur, and it is unlikely to happen soon.
This reality highlights the importance for wealthy nations to take more decisive action to assist in vaccinating the rest of the world as rapidly as possible. This effort is crucial for achieving endemicity sooner. Even if universal coverage is not attainable, increasing vaccination rates will still yield significant benefits. Mass vaccination would decrease the likelihood of new variants emerging, lower mortality rates, and mitigate the extensive impacts — medical, economic, psychological, and social — associated with long-term symptoms.
I can understand the lack of urgency felt by individuals in vaccinated countries. After all, in places like the U.S., vaccines are readily available. Once vaccinated, it is natural to feel relieved. However, until global immunity is achieved, that sense of relief is, at least in part, misleading.
We are all in this together. Beyond the moral imperative to help others, there is a compelling self-interest for vaccinated individuals in affluent countries to advocate for global vaccination. The math and biological realities necessitate this. Simply securing vaccines for ourselves is insufficient; the rest of the world must also gain access.
Chapter 2: Understanding the Global Vaccination Landscape
This video titled "Covid-19: What Will It Take to Vaccinate the World?" explores the challenges and strategies involved in achieving global vaccination coverage.
In the video "How to Vaccinate the World Next Time," experts discuss lessons learned from the Covid-19 pandemic and how to prepare for future vaccination efforts.